| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |